» Articles » PMID: 36203828

Efficacy and Safety of Daily Home-based Transcranial Direct Current Stimulation As Adjunct Treatment for Bipolar Depressive Episodes: Double-blind Sham-controlled Randomized Clinical Trial

Abstract

Background: Although transcranial direct current stimulation (tDCS) is known to be a promising therapeutic modality for unipolar depression, the efficacy and safety of tDCS for bipolar depressive episodes (BD) are still unknown and clinical trials of home-based tDCS treatment are scarce. As a result, we set out to investigate the efficacy and safety of home-based tDCS for the treatment BD.

Methods: Participants ( = 64), diagnosed as bipolar disorder as per the diagnostic and statistical manual of mental disorders (DSM-5), were randomly assigned to receive tDCS. Hamilton Depression Rating Scale (HDRS-17) scores were measured at the baseline, week 2, 4, and 6, and home-based tDCS (for 30 min with 2 mA) was self-administered daily.

Results: Of the 64 patients (15.6% bipolar disorder I, 84.4% bipolar disorder II), 41 patients completed the entire assessment. In the intention-to-treat analysis, time-group interaction for the HDRS-17 [ = 2.060; = 0.108] and adverse effect differences between two groups were not statistically significant, except the pain score, which was higher in the active group than the sham group (week 0-2: < 0.01, week 2-4: < 0.05, and week 4-6: < 0.01).

Conclusion: Even though we found no evidence for the efficacy of home-based tDCS for patients with BD, this tool was found to be a safe and tolerable treatment modality for BD.

Clinical Trial Registration: [https://clinicaltrials.gov/show/NCT03974815], identifier [NCT03974815].

Citing Articles

Efficacy and safety of home-based transcranial direct current stimulation as adjunct treatment for cognitive improvement in major depressive disorder: A double-blind, randomized, multi-site clinical trial.

Lee C, Park K, Ahn J, Jang Y, Park Y, Yu H Eur Psychiatry. 2025; 68(1):e15.

PMID: 39809704 PMC: 11822958. DOI: 10.1192/j.eurpsy.2024.1811.


The effectiveness of home-based transcranial direct current stimulation on chronic pain: A systematic review and meta-analysis.

Antonioni A, Baroni A, Fregna G, Ahmed I, Straudi S Digit Health. 2024; 10:20552076241292677.

PMID: 39600390 PMC: 11590159. DOI: 10.1177/20552076241292677.


Home-based transcranial direct current stimulation in bipolar depression: an open-label treatment study of clinical outcomes, acceptability and adverse events.

Ghazi-Noori A, Woodham R, Rezaei H, Sharif M, Bramon E, Ritter P Int J Bipolar Disord. 2024; 12(1):30.

PMID: 39162912 PMC: 11336151. DOI: 10.1186/s40345-024-00352-9.


Treating depression at home with transcranial direct current stimulation: a feasibility study.

Dragon K, Abdelnaim M, Weber F, Heuschert M, Englert L, Langguth B Front Psychiatry. 2024; 15:1335243.

PMID: 38501089 PMC: 10944921. DOI: 10.3389/fpsyt.2024.1335243.


Transcranial direct current stimulation as treatment for major depression in a home treatment setting (HomeDC trial): study protocol and methodology of a double-blind, placebo-controlled pilot study.

Kumpf U, Ezim H, Stadler M, Burkhardt G, Palm U, Dechantsreiter E Pilot Feasibility Stud. 2023; 9(1):197.

PMID: 38102647 PMC: 10722795. DOI: 10.1186/s40814-023-01423-x.


References
1.
Judd L, Akiskal H, Schettler P, Endicott J, Maser J, Solomon D . The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002; 59(6):530-7. DOI: 10.1001/archpsyc.59.6.530. View

2.
Galvez V, Alonzo A, Martin D, Mitchell P, Sachdev P, Loo C . Hypomania induction in a patient with bipolar II disorder by transcranial direct current stimulation (tDCS). J ECT. 2011; 27(3):256-8. DOI: 10.1097/YCT.0b013e3182012b89. View

3.
Goodwin G, Haddad P, Ferrier I, Aronson J, Barnes T, Cipriani A . Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2016; 30(6):495-553. PMC: 4922419. DOI: 10.1177/0269881116636545. View

4.
Baldessarini R, Vazquez G, Tondo L . Bipolar depression: a major unsolved challenge. Int J Bipolar Disord. 2020; 8(1):1. PMC: 6943098. DOI: 10.1186/s40345-019-0160-1. View

5.
Lees G, Leach M . Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex. Brain Res. 1993; 612(1-2):190-9. DOI: 10.1016/0006-8993(93)91660-k. View